IRADIMED CORPORATION Statistics
Total Valuation
IRMD has a market cap or net worth of $658.26 million. The enterprise value is $606.18 million.
| Market Cap | 658.26M |
| Enterprise Value | 606.18M |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025, before market open.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | Feb 24, 2025 |
Share Statistics
IRMD has 12.72 million shares outstanding. The number of shares has increased by 0.48% in one year.
| Current Share Class | 12.72M |
| Shares Outstanding | 12.72M |
| Shares Change (YoY) | +0.48% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 36.86% |
| Owned by Institutions (%) | 48.07% |
| Float | 7.12M |
Valuation Ratios
The trailing PE ratio is 34.51 and the forward PE ratio is 32.26.
| PE Ratio | 34.51 |
| Forward PE | 32.26 |
| PS Ratio | 8.96 |
| Forward PS | 8.13 |
| PB Ratio | 7.58 |
| P/TBV Ratio | 7.86 |
| P/FCF Ratio | 37.36 |
| P/OCF Ratio | 25.69 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.61, with an EV/FCF ratio of 34.40.
| EV / Earnings | 31.52 |
| EV / Sales | 8.28 |
| EV / EBITDA | 26.61 |
| EV / EBIT | 27.60 |
| EV / FCF | 34.40 |
Financial Position
The company has a current ratio of 8.84, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.84 |
| Quick Ratio | 7.38 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 24.31% and return on invested capital (ROIC) is 17.11%.
| Return on Equity (ROE) | 24.31% |
| Return on Assets (ROA) | 14.41% |
| Return on Invested Capital (ROIC) | 17.11% |
| Return on Capital Employed (ROCE) | 24.46% |
| Revenue Per Employee | $457,763 |
| Profits Per Employee | $120,213 |
| Employee Count | 160 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 1.45 |
Taxes
In the past 12 months, IRMD has paid $5.04 million in taxes.
| Income Tax | 5.04M |
| Effective Tax Rate | 20.77% |
Stock Price Statistics
The stock price has increased by +25.52% in the last 52 weeks. The beta is 0.83, so IRMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +25.52% |
| 50-Day Moving Average | 53.75 |
| 200-Day Moving Average | 51.59 |
| Relative Strength Index (RSI) | 47.77 |
| Average Volume (20 Days) | 39,270 |
Short Selling Information
The latest short interest is 188,095, so 1.48% of the outstanding shares have been sold short.
| Short Interest | 188,095 |
| Short Previous Month | 236,970 |
| Short % of Shares Out | 1.48% |
| Short % of Float | 2.64% |
| Short Ratio (days to cover) | 5.00 |
Income Statement
In the last 12 months, IRMD had revenue of $73.24 million and earned $19.23 million in profits. Earnings per share was $1.50.
| Revenue | 73.24M |
| Gross Profit | 56.35M |
| Operating Income | 21.96M |
| Pretax Income | 23.60M |
| Net Income | 19.23M |
| EBITDA | 22.78M |
| EBIT | 21.96M |
| Earnings Per Share (EPS) | $1.50 |
Balance Sheet
The company has $52.23 million in cash and $154,688 in debt, giving a net cash position of $52.08 million or $4.10 per share.
| Cash & Cash Equivalents | 52.23M |
| Total Debt | 154,688 |
| Net Cash | 52.08M |
| Net Cash Per Share | $4.10 |
| Equity (Book Value) | 86.82M |
| Book Value Per Share | 6.83 |
| Working Capital | 66.73M |
Cash Flow
In the last 12 months, operating cash flow was $25.62 million and capital expenditures -$8.01 million, giving a free cash flow of $17.62 million.
| Operating Cash Flow | 25.62M |
| Capital Expenditures | -8.01M |
| Free Cash Flow | 17.62M |
| FCF Per Share | $1.39 |
Margins
Gross margin is 76.94%, with operating and profit margins of 29.99% and 26.26%.
| Gross Margin | 76.94% |
| Operating Margin | 29.99% |
| Pretax Margin | 33.14% |
| Profit Margin | 26.26% |
| EBITDA Margin | 31.11% |
| EBIT Margin | 29.99% |
| FCF Margin | 24.06% |
Dividends & Yields
This stock pays an annual dividend of $0.68, which amounts to a dividend yield of 1.32%.
| Dividend Per Share | $0.68 |
| Dividend Yield | 1.32% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 45.33% |
| Buyback Yield | -0.48% |
| Shareholder Yield | 0.84% |
| Earnings Yield | 2.92% |
| FCF Yield | 2.68% |
Analyst Forecast
The average price target for IRMD is $72.00, which is 39.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $72.00 |
| Price Target Difference | 39.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRMD has an Altman Z-Score of 33.74 and a Piotroski F-Score of 7.
| Altman Z-Score | 33.74 |
| Piotroski F-Score | 7 |